Quote | Aldeyra Therapeutics Inc. (NASDAQ:ALDX)
|Last Trade Date Time:||10/02/2023 03:00:00 am|
News | Aldeyra Therapeutics Inc. (NASDAQ:ALDX)
2023-09-22 19:44:16 ET Summary Aldeyra is a late-stage company developing therapies for immune-mediated diseases, with a focus on dry eye disease and allergic conjunctivitis. Their lead asset, reproxalap, is under NDA review for dry eye disease and has shown positive results in ph...
2023-09-18 18:10:11 ET Summary Aldeyra Therapeutics' Q2 2023 report reveals a 52% cut in R&D spending, signaling a shift towards market readiness and commercial activities. The company maintains strong financial health with $151.7M cash reserves and a 40-month cash runway, red...
Message Board Posts | Aldeyra Therapeutics Inc. (NASDAQ:ALDX)
|MomentumIts gaining||make it happen||investorshub||06/19/2023 11:09:28 PM|
|$ALDX Lets go go go go... Up up and away we go.||Rayn_Makr||investorshub||06/19/2023 4:35:19 PM|
|$ALDX Anyone hear anything lately? Want to see this one go||TheFinalCD||investorshub||06/18/2023 5:23:18 PM|
|Good news recently, we should start to see this one move||Rayn_Makr||investorshub||06/18/2023 5:01:33 PM|
|Price gaining up||Investor2014||investorshub||06/18/2023 2:05:59 AM|
Aldeyra Therapeutics Inc. Company Name:
ALDX Stock Symbol:
Aldeyra Therapeutics Inc. Website:
U.S. stock futures traded higher this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session. V...
NEW YORK, Sept. 02, 2023 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Lifshitz Law PLLC announces investigation into possible s...
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 28, 2023 (GLOBE NEWSWIRE) -- The Por...